This operation seeks to strengthen and advance the development of medicines that contribute to improving the efficiency (cost, time) and effectiveness (clinical and socio-economic impact) of this process. Innovative research projects covering the different phases of drug discovery will be addressed, from the identification/validation of a target to the preclinical and clinical evaluation of new drugs. This action is coordinated by the IIS La Fe and the IPPC and INCLIVA also participate in it.